Matches in Nanopublications for { ?s ?p "[The RHAMM (CD168) gene, earlier identified by our group as an immunogenic antigen in acute and chronic leukemia, also showed highly significant overexpression in CaP metastases compared with localized disease and benign prostatic hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP755510.RAQD8vdWpvxJwtmkHw844It6To1_VYDDcFkTSCWyRYCIw130_assertion description "[The RHAMM (CD168) gene, earlier identified by our group as an immunogenic antigen in acute and chronic leukemia, also showed highly significant overexpression in CaP metastases compared with localized disease and benign prostatic hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP755510.RAQD8vdWpvxJwtmkHw844It6To1_VYDDcFkTSCWyRYCIw130_provenance.
- NP936436.RApTD0jNejxOyYyk6Qk9r8rYJngVyR3IDD6NMpdI7tek0130_assertion description "[The RHAMM (CD168) gene, earlier identified by our group as an immunogenic antigen in acute and chronic leukemia, also showed highly significant overexpression in CaP metastases compared with localized disease and benign prostatic hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP936436.RApTD0jNejxOyYyk6Qk9r8rYJngVyR3IDD6NMpdI7tek0130_provenance.
- NP163225.RA9t-uc-Uc_6ZxEknhstnNYAeWkv8eGrz0GRC4Rpwz4w8130_assertion description "[The RHAMM (CD168) gene, earlier identified by our group as an immunogenic antigen in acute and chronic leukemia, also showed highly significant overexpression in CaP metastases compared with localized disease and benign prostatic hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP163225.RA9t-uc-Uc_6ZxEknhstnNYAeWkv8eGrz0GRC4Rpwz4w8130_provenance.
- NP817877.RA3QYnrQp-9IKutS41OJxH3kmlpBUSpX1v-9ycdq2tl6c130_assertion description "[The RHAMM (CD168) gene, earlier identified by our group as an immunogenic antigen in acute and chronic leukemia, also showed highly significant overexpression in CaP metastases compared with localized disease and benign prostatic hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP817877.RA3QYnrQp-9IKutS41OJxH3kmlpBUSpX1v-9ycdq2tl6c130_provenance.
- NP416045.RA03VDushdLOuva3AMBPjqE_-_n4YewvB_BAWf7-kLdqc130_assertion description "[The RHAMM (CD168) gene, earlier identified by our group as an immunogenic antigen in acute and chronic leukemia, also showed highly significant overexpression in CaP metastases compared with localized disease and benign prostatic hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP416045.RA03VDushdLOuva3AMBPjqE_-_n4YewvB_BAWf7-kLdqc130_provenance.
- NP875991.RAzYCZbbYCO0JBBTnzox5dtTpObCNa3f2nvXJqubRCatQ130_assertion description "[The RHAMM (CD168) gene, earlier identified by our group as an immunogenic antigen in acute and chronic leukemia, also showed highly significant overexpression in CaP metastases compared with localized disease and benign prostatic hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP875991.RAzYCZbbYCO0JBBTnzox5dtTpObCNa3f2nvXJqubRCatQ130_provenance.
- NP460161.RA5s-Bqwobq9SkdNghv15b1-CcKY7UQLMTk1kOEmFXO6Y130_assertion description "[The RHAMM (CD168) gene, earlier identified by our group as an immunogenic antigen in acute and chronic leukemia, also showed highly significant overexpression in CaP metastases compared with localized disease and benign prostatic hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP460161.RA5s-Bqwobq9SkdNghv15b1-CcKY7UQLMTk1kOEmFXO6Y130_provenance.
- NP460174.RAS4J8Dngcm7IlEpeNkmuYphRhOVAAVLkoJAtP3bA57RQ130_assertion description "[The RHAMM (CD168) gene, earlier identified by our group as an immunogenic antigen in acute and chronic leukemia, also showed highly significant overexpression in CaP metastases compared with localized disease and benign prostatic hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP460174.RAS4J8Dngcm7IlEpeNkmuYphRhOVAAVLkoJAtP3bA57RQ130_provenance.
- assertion description "[The RHAMM (CD168) gene, earlier identified by our group as an immunogenic antigen in acute and chronic leukemia, also showed highly significant overexpression in CaP metastases compared with localized disease and benign prostatic hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The RHAMM (CD168) gene, earlier identified by our group as an immunogenic antigen in acute and chronic leukemia, also showed highly significant overexpression in CaP metastases compared with localized disease and benign prostatic hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP760726.RAWsOqpqnkW2FxUxapYI0gU3eyeLoqG1UUQdeTRch08Kk130_assertion description "[The RHAMM (CD168) gene, earlier identified by our group as an immunogenic antigen in acute and chronic leukemia, also showed highly significant overexpression in CaP metastases compared with localized disease and benign prostatic hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP760726.RAWsOqpqnkW2FxUxapYI0gU3eyeLoqG1UUQdeTRch08Kk130_provenance.
- NP760725.RAIFfXvLrvleEp18Oay76JyGZmIHhYvth1zdC1fsBe15A130_assertion description "[The RHAMM (CD168) gene, earlier identified by our group as an immunogenic antigen in acute and chronic leukemia, also showed highly significant overexpression in CaP metastases compared with localized disease and benign prostatic hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP760725.RAIFfXvLrvleEp18Oay76JyGZmIHhYvth1zdC1fsBe15A130_provenance.